German stem cell licence for Parkinson's research:
This article was originally published in Clinica
Germany's Robert Koch Institute for infectious diseases has issued its fifth licence for the importing of stems cells for research purposes to the Max Planck Institute for biophysical chemistry in Gottingen. The project for which the licence has been granted concerns the differentiation of human embryonic stem cells in dopamine neurons. The institute hopes the project will lead to a better understanding of the physiological processes of the brain as well as its failures, which are linked to Parkinson's disease.